udt-logo-verdana-white-3
  • About us
  • Investment focus
  • Team
  • Investment proposal
  • contact
  • en
  • nl
News item Orgonex samenwerking prinses maxima centrum
  1. Home›
  2. News›
  3. RPMotion for pediatric (tumor) organoids
Published on: March 2, 2026

RPMotion for pediatric (tumor) organoids

Originally posted on: Orgonex
At the Princess Máxima Center for pediatric oncology researchers are growing pediatric tumor organoids to establish the Central Máxima Organoid Biobank (CMOB). This essential work is traditionally time-consuming. To optimize this process, Karin Sanders (Associate group leader Máxima Clevers group & head of Central Máxima Organoid Biobank) and Jarno Drost (Professor at the Princess Máxima Center) will test the RPMotion bioreactor from Orgonex. This innovative technology is designed to grow organoids more efficiently, significantly reducing the manual labor and materials required.

We are proud and grateful to collaborate with the Princess Máxima Center for pediatric oncology for this critical research in the fight against childhood cancer!


News preview Orgonex samenwerking prinses maxima centrum
udt-logo-verdana-white-3
About usInvestment focusTeamInvestment proposal

Contact us

send a message
cookie policyprivacy statement
© 2026 UDT. All rights reserved.